This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
29 Sep 2015 | Global | Technology Research
Transforming cancer treatment with Immunotherapy (TechVision)
Fight cancer with Immunotherapy
This research service focuses on the current status of candidates for opioid therapeutics with a focus on current Phase 3 candidates, detailed timelines, rational for pivotal program design, Phase 2 data review and key opinion leader (KOL) commentary. A pipeline assessment is provided for all active candidates in development. The information contai...
$4,950.00 -
28 Sep 2015 | Global | Market Research
Vital Signs The Analyst's Perspective - August 2015 Issue
This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.
$450.00 -
Cell therapy is the fastest growing segment of the Regenerative Medicine (RM) industry. It comprises both immune cell therapy and stem cell therapy; however, stem cell therapy makes up the largest part of this segment. The global cell therapy market is driven by the success of stem cell treatments in treating or curing life-threatening diseases suc...
$1,500.00 -
12 Aug 2015 | Global | Market Research
Singapore Contract Research Organization Market
Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.
The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...
$1,500.00 -
07 Aug 2015 | Global | Market Research
Indian Contract Research Organization (CRO) Market
The Evolving Regulatory Scenario is Likely to Boost Market Growth
This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...
$1,500.00 -
This issue profiles a novel blood pumping device to aid heart failure patients, an ultrasound diagnostic tool for bone strength assessment, and a wearable maternal-fetal monitor to improve prenatal health.
$950.00 -
This issue profiles development of a triboelectric nanogenerator, biomechanical energy harvesting with piezoelectric nanogenerators, and chemotherapy enabled by nanoparticles treats cancer stem-like cells.
$250.00 -
This issue profiles a high-priced hepatitis c drug that results in development of generic products, a rapid antigen test for Ebola, and focused antiviral clinical programs for infectious diseases.
$250.00 -
This issue profiles an imaging app for ultrasound, a compatible leads for MRI systems, and innovative contrast agents for preclinical imaging.
$950.00 -
This issue profiles a drug for oculopharyngeal muscular dystrophy treatment that receives orphan drug designation; non-viral CFTR-based gene therapy for cystic fibrosis patients, a breast cancer diagnostic test in Europe.
$250.00
